Zdenka Jonak
13Patents
5h-index
28Co-inventors
66Inventor score
Filing activity: Jul 5, 1983 → Jun 26, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4652522A | Continuous lymphocyte cell lines, their production and use | Emerging Cross-Sectional Technologies | 12 | Expired |
| US6160099A | Anti-human .alpha..sub.v .beta..sub.3 and .alpha..sub.v .beta..sub.5 antibodies | Chemistry; Metallurgy | 10 | Expired |
| US7311902B2 | Conjugates comprising human IL-18 and substitution mutants thereof | Human Necessities | 10 | Expired |
| US7230083B2 | Anti-alphabeta3 humanized monoclonal antibodies | Chemistry; Metallurgy | 9 | Expired |
| US7736639B2 | Method of treating cancer by administering conjugates comprising human IL-18 and substitution mutants thereof | Human Necessities | 5 | Active |
| US7220557B2 | METH1 polynucleotides | Chemistry; Metallurgy | 5 | Expired |
| US7087405B2 | Nucleic acids encoding anti-human ανβ3 and ανβ5 antibodies | Chemistry; Metallurgy | 3 | Expired |
| US5580720A | Human lymphoid cells expressing human immunodeficiency virus envelope protein gp160 | Emerging Cross-Sectional Technologies | 1 | Expired |
| US5462872A | Human lymphoid cells expressing human immunodeficiency virus envelope protein GP160 | Emerging Cross-Sectional Technologies | 1 | Expired |
| US8496932B2 | Compounds | Chemistry; Metallurgy | 1 | Active |
| US9085622B2 | Antigen binding proteins | Chemistry; Metallurgy | 0 | Active |
| US8828384B2 | Compounds | Chemistry; Metallurgy | 0 | Active |
| US7504102B2 | Anti-αvβ3 humanized monoclonal antibodies | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.